2jog Citations

Structure of the calcineurin-NFAT complex: defining a T cell activation switch using solution NMR and crystal coordinates.

Structure 15 587-97 (2007)
Cited: 36 times
EuropePMC logo PMID: 17502104

Abstract

Calcineurin (Cn) is a serine/threonine protein phosphatase that plays pivotal roles in many physiological processes, including cell proliferation, development, and apoptosis. Most prominently, Cn targets the nuclear factors of activated T cell (NFATs), transcription factors that activate cytokine genes. Calcium-activated Cn dephosphorylates multiple residues within the regulatory domain of NFAT, triggering joint nuclear translocation. This relies crucially on the interaction between the catalytic domain of Cn (CnCat) and the conserved PxIxIT motif located in a region distinct from the dephosphorylation sites of NFAT. Here, we present the structure of the complex between the 39 kDa CnCat and a 14 residue peptide containing a PVIVIT segment that was derived from affinity-driven peptide selection based on the conserved PxIxIT motif of NFATs. The structure of the complex was determined by using NMR assignments and structural constraints and the coordinates of the CnCat crystal structure. The NMR analysis relied on recently developed labeling and spectroscopic techniques. The VIVIT peptide is accommodated in a hydrophobic cleft formed by beta strands 11 and 14, and the loop between beta strands 11 and 12, forming a short parallel beta sheet with the exposed beta strand 14 in Cn. The side chains of conserved residues in the PxIxIT sequences make extensive interactions with conserved residues in Cn, while those of nonconserved residues are solvent exposed. The architecture of the interface explains the diversity of recognition sequences compatible with NFAT function and uncovers a potential targeting site for immune-suppressive agents. The structure reveals that the orientation of the bound PxIxIT directs the phosphorylation sites in NFAT's regulatory domain toward the Cn catalytic site.

Articles - 2jog mentioned but not cited (3)

  1. NMR resonance assignments of the catalytic domain of human serine/threonine phosphatase calcineurin in unligated and PVIVIT-peptide-bound states. Takeuchi K, Sun ZY, Li S, Gal M, Wagner G. Biomol NMR Assign 9 201-205 (2015)
  2. Cis-trans proline isomers in the catalytic domain of calcineurin. Teixeira JMC, Guasch A, Biçer A, Aranguren-Ibáñez Á, Chashmniam S, Paniagua JC, Pérez-Riba M, Fita I, Pons M. FEBS J 286 1230-1239 (2019)
  3. Funneling modulatory peptide design with generative models: Discovery and characterization of disruptors of calcineurin protein-protein interactions. Tubiana J, Adriana-Lifshits L, Nissan M, Gabay M, Sher I, Sova M, Wolfson HJ, Gal M. PLoS Comput Biol 19 e1010874 (2023)


Reviews citing this publication (10)

  1. Serine/threonine phosphatases: mechanism through structure. Shi Y. Cell 139 468-484 (2009)
  2. The road less traveled: modulating signal transduction enzymes by inhibiting their protein-protein interactions. Arkin MR, Whitty A. Curr Opin Chem Biol 13 284-290 (2009)
  3. Short linear motifs - ex nihilo evolution of protein regulation. Davey NE, Cyert MS, Moses AM. Cell Commun Signal 13 43 (2015)
  4. Nuclear factor of activated T cells in cancer development and treatment. Shou J, Jing J, Xie J, You L, Jing Z, Yao J, Han W, Pan H. Cancer Lett 361 174-184 (2015)
  5. The Emerging Roles of the Calcineurin-Nuclear Factor of Activated T-Lymphocytes Pathway in Nervous System Functions and Diseases. Kipanyula MJ, Kimaro WH, Seke Etet PF. J Aging Res 2016 5081021 (2016)
  6. Functional diversity and pharmacological profiles of the FKBPs and their complexes with small natural ligands. Galat A. Cell Mol Life Sci 70 3243-3275 (2013)
  7. Detection of intermolecular NOE interactions in large protein complexes. Anglister J, Srivastava G, Naider F. Prog Nucl Magn Reson Spectrosc 97 40-56 (2016)
  8. Recent progress on the structure of Ser/Thr protein phosphatases. Wang B, Zhang P, Wei Q. Sci China C Life Sci 51 487-494 (2008)
  9. Transient disorder: Calcineurin as an example. Creamer TP. Intrinsically Disord Proteins 1 e26412 (2013)
  10. Targeting CaN/NFAT in Alzheimer's brain degeneration. Mackiewicz J, Lisek M, Boczek T. Front Immunol 14 1281882 (2023)

Articles citing this publication (23)

  1. Balanced interactions of calcineurin with AKAP79 regulate Ca2+-calcineurin-NFAT signaling. Li H, Pink MD, Murphy JG, Stein A, Dell'Acqua ML, Hogan PG. Nat Struct Mol Biol 19 337-345 (2012)
  2. The molecular mechanism of substrate engagement and immunosuppressant inhibition of calcineurin. Grigoriu S, Bond R, Cossio P, Chen JA, Ly N, Hummer G, Page R, Cyert MS, Peti W. PLoS Biol 11 e1001492 (2013)
  3. The Crz1/Sp1 transcription factor of Cryptococcus neoformans is activated by calcineurin and regulates cell wall integrity. Lev S, Desmarini D, Chayakulkeeree M, Sorrell TC, Djordjevic JT. PLoS One 7 e51403 (2012)
  4. Inhibiting the calcineurin-NFAT (nuclear factor of activated T cells) signaling pathway with a regulator of calcineurin-derived peptide without affecting general calcineurin phosphatase activity. Mulero MC, Aubareda A, Orzáez M, Messeguer J, Serrano-Candelas E, Martínez-Hoyer S, Messeguer A, Pérez-Payá E, Pérez-Riba M. J Biol Chem 284 9394-9401 (2009)
  5. The RCAN carboxyl end mediates calcineurin docking-dependent inhibition via a site that dictates binding to substrates and regulators. Martínez-Martínez S, Genescà L, Rodríguez A, Raya A, Salichs E, Were F, López-Maderuelo MD, Redondo JM, de la Luna S. Proc Natl Acad Sci U S A 106 6117-6122 (2009)
  6. High-throughput screening of one-bead-one-compound libraries: identification of cyclic peptidyl inhibitors against calcineurin/NFAT interaction. Liu T, Qian Z, Xiao Q, Pei D. ACS Comb Sci 13 537-546 (2011)
  7. Investigating the human Calcineurin Interaction Network using the πɸLxVP SLiM. Sheftic SR, Page R, Peti W. Sci Rep 6 38920 (2016)
  8. Calcineurin interacts with the serotonin transporter C-terminus to modulate its plasma membrane expression and serotonin uptake. Seimandi M, Seyer P, Park CS, Vandermoere F, Chanrion B, Bockaert J, Mansuy IM, Marin P. J Neurosci 33 16189-16199 (2013)
  9. Intermolecular interactions in a 44 kDa interferon-receptor complex detected by asymmetric reverse-protonation and two-dimensional NOESY. Nudelman I, Akabayov SR, Schnur E, Biron Z, Levy R, Xu Y, Yang D, Anglister J. Biochemistry 49 5117-5133 (2010)
  10. Identification of small-molecule inhibitors of calcineurin-NFATc signaling that mimic the PxIxIT motif of calcineurin binding partners. Matsoukas MT, Aranguren-Ibáñez Á, Lozano T, Nunes V, Lasarte JJ, Pardo L, Pérez-Riba M. Sci Signal 8 ra63 (2015)
  11. Leveraging New Definitions of the LxVP SLiM To Discover Novel Calcineurin Regulators and Substrates. Brauer BL, Moon TM, Sheftic SR, Nasa I, Page R, Peti W, Kettenbach AN. ACS Chem Biol 14 2672-2682 (2019)
  12. Physical interaction between calcineurin and Cav3.2 T-type Ca2+ channel modulates their functions. Huang CH, Chen YC, Chen CC. FEBS Lett 587 1723-1730 (2013)
  13. Calmodulin-Calcineurin Interaction beyond the Calmodulin-Binding Region Contributes to Calcineurin Activation. Sun B, Vaughan D, Tikunova S, Creamer TP, Davis JP, Kekenes-Huskey PM. Biochemistry 58 4070-4085 (2019)
  14. Structure-based optimization of a peptidyl inhibitor against calcineurin-nuclear factor of activated T cell (NFAT) interaction. Qian Z, Dougherty PG, Liu T, Oottikkal S, Hogan PG, Hadad CM, Pei D. J Med Chem 57 7792-7797 (2014)
  15. Traffic-related PM2.5 induces cytosolic [Ca²⁺] increase regulated by Orai1, alters the CaN-NFAT signaling pathway, and affects IL-2 and TNF-α cytoplasmic levels in Jurkat T-cells. Tong GQ, Zhang ZH, Zhao Y, Liu JJ, Han JB. Arch Environ Contam Toxicol 68 31-37 (2015)
  16. Calcineurin Undergoes a Conformational Switch Evoked via Peptidyl-Prolyl Isomerization. Guasch A, Aranguren-Ibáñez Á, Pérez-Luque R, Aparicio D, Martínez-Høyer S, Mulero MC, Serrano-Candelas E, Pérez-Riba M, Fita I. PLoS One 10 e0134569 (2015)
  17. Calcineurin regulatory subunit B is a unique calcium sensor that regulates calcineurin in both calcium-dependent and calcium-independent manner. Li J, Jia Z, Zhou W, Wei Q. Proteins 77 612-623 (2009)
  18. Observation of intermolecular interactions in large protein complexes by 2D-double difference nuclear Overhauser enhancement spectroscopy: application to the 44 kDa interferon-receptor complex. Nudelman I, Akabayov SR, Scherf T, Anglister J. J Am Chem Soc 133 14755-14764 (2011)
  19. The LxVP and PxIxIT NFAT motifs bind jointly to overlapping epitopes on calcineurin's catalytic domain distant to the regulatory domain. Gal M, Li S, Luna RE, Takeuchi K, Wagner G. Structure 22 1016-1027 (2014)
  20. Domains involved in calcineurin phosphatase inhibition and nuclear localisation in the African swine fever virus A238L protein. Abrams CC, Chapman DA, Silk R, Liverani E, Dixon LK. Virology 374 477-486 (2008)
  21. Mechanism of activation of Saccharomyces cerevisiae calcineurin by Mn2+. Ren Y, Wang ZX, Wei Q. Biol Chem 390 1155-1162 (2009)
  22. The optimized core peptide derived from CABIN1 efficiently inhibits calcineurin-mediated T-cell activation. Lee S, Lee HT, Kim YA, Lee IH, Kang SJ, Sim K, Park CG, Choi K, Youn HD. Exp Mol Med 54 613-625 (2022)
  23. The Role of NFATC4 Gene in Human Cutaneous Squamous Cell Carcinoma. Li F, Chen H, Lu X. Indian J Dermatol 68 156-160 (2023)